[225Ac]Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: efficacy and treatment outcome

被引：0
|
作者：
Ebrahimifard, A. [1 ]
Bagheri, S. [1 ]
Wang, Q. [1 ]
Eilsberger, F. [1 ]
Luster, M. [1 ]
Librizzi, D. [1 ]
Yousefi, B. H. [1 ]
机构：
[1] Philipps Univ Marburg, Marburg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-760
引用
收藏
页码：S360 / S360
页数：1
相关论文
共 50 条
  • [41] [225Ac]Ac-PSMA-617 augmented [177Lu]Lu-PSMA-617 RLT in challenging advanced mCRPC patients
    Rosar, F.
    Krause, J.
    Bartholomae, M.
    Maus, S.
    Stemler, T.
    Hierlmeier, I.
    Linxweiler, J.
    Ezziddin, S.
    Khreish, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S315 - S315
  • [42] Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy
    Sathekge, Mike
    Bruchertseifer, Frank
    Vorster, Mariza
    Lawal, Ismaheel O.
    Knoesen, Otto
    Mahapane, Johncy
    Davis, Cindy
    Reyneke, Florette
    Maes, Alex
    Kratochwil, Clemens
    Lengana, Thabo
    Giesel, Frederik L.
    Van de Wiele, Christophe
    Morgenstern, Alfred
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (01) : 62 - 69
  • [43] Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen)
    Belli, Maria Luisa
    Sarnelli, Anna
    Mezzenga, Emilio
    Cesarini, Francesco
    Caroli, Paola
    Di Iorio, Valentina
    Strigari, Lidia
    Cremonesi, Marta
    Romeo, Antonino
    Nicolini, Silvia
    Matteucci, Federica
    Severi, Stefano
    Paganelli, Giovanni
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Deescalated 225 Ac-PSMA-617 Versus 177 Lu/ 225 Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients
    Rathke, Hendrik
    Winter, Erik
    Bruchertseifer, Frank
    Roehrich, Manuel
    Giesel, Frederik Lars
    Haberkorn, Uwe
    Morgenstern, Alfred
    Kratochwil, Clemens
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (07) : 1057 - 1063
  • [45] Therapeutic efficacy and clinical outcome of 177Lu-PSMA-617/225Ac-PSMA-617 radioligand therapy in metastatic castration resistant prostate cancer (mCRPC) - single institutional experience from India
    Kalra, Kriti
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [46] Labeling process and quality control results of 225Ac-PSMA-617 for targeted alpha particle therapy for metastatic prostate cancer
    Shukurov, Razim
    Veliyev, Mirsaleh
    Dadashov, Zamil
    Isayev, Jeyhun
    Novruzov, Fuad
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [47] 177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival
    Demirci, E.
    Akyel, R.
    Sahin, O.
    Ocak, M.
    Aygun, A.
    Pehlivanoglu, H.
    Karayel, E.
    Kabasakal, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S202 - S203
  • [48] Preliminary efficacy and safety results from the (TATCIST) trial: A PSMA-directed targeted alpha therapy with FPI-2265 (225Ac-PSMA-I&T) for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
    Delpassand, Ebrahim S.
    Hashmi, Mohammad Jawed
    Kazakin, Julia
    Nawaz, Omer
    Garufi, Gabriella
    Schindler, Joanne
    Nordquist, Luke
    CANCER RESEARCH, 2024, 84 (07)
  • [49] Novel 212Pb-PSMA Targeted Alpha Therapy for the Treatment of Metastatic Castration-Resistant Prostate Cancer
    Kryza, T.
    Liu, F.
    Li, K. C.
    Francis, P.
    Kuan, K.
    Tieu, W.
    Akhter, D.
    Fletcher, N.
    Taylor, S.
    Karmann, A.
    Rose, S.
    Puttick, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S254 - S255
  • [50] CKD After 225Ac-PSMA617 Therapy in Patients With Metastatic Prostate Cancer
    Pelletier, Karyne
    Cote, Gabrielle
    Fallah-Rad, Nazanin
    John, Rohan
    Kitchlu, Abhijat
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (03): : 853 - 856
12345